(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Tuesday and not separately reported by Alliance News: Read More
(Alliance News) - Shield Therapeutics PLC on Tuesday said it plans a share offer to raise fresh funds, while it also has agreed a sales collaboration with Viatris Inc in the US for the oral therapy Accrufer. Read More
(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Monday and not separately reported by Alliance News: Read More
(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Thursday and not separately reported by Alliance News: Read More
(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Thursday and not separately reported by Alliance News: Read More
Shield Therapeutics PLC - Newcastle, England-based commercial-stage pharmaceutical company - Existing shareholder AOP Health International Management agrees to loan USD10 million to Shield, which will draw it down in a single tranche, and being secured over Shield's US intellectual property rights. Read More
(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Thursday and not separately reported by Alliance News: Read More
(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Thursday and not separately reported by Alliance News: Read More
(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Monday and not separately reported by Alliance News: Read More
(Alliance News) - Shield Therapeutics PLC's shares tumbled on Thursday after a trading update revealed a substantial, but expected, fall in revenue. Read More
